a menu icon
a back arrow
Sonoma Bio Home

Press Releases

Sonoma Biotherapeutics Expands Series A Financing to $70 Million and Appoints Key Executives to Advance Regulatory T-cell Therapies in Autoimmune and Degenerative Diseases

September 30, 2020
Sonoma Biotherapeutics launches with $40 million in Series A funding to advance regulatory T cell therapy in autoimmune and degenerative diseases

February 6, 2020
HomeMissionCultureTeamSciencePipelineCareersNewsContact
HOMEMissionCultureTeamSciencePipelineCareersInvestorsNewsContact